日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Management of laryngeal chondroradionecrosis: A single-center experience

喉软骨放射性坏死的治疗：单中心经验

期刊:Head and Neck-Journal for the Sciences and Specialties of the Head and Neck
影响因子:2.2
doi:10.1002/hed.27919
Levin, Einav G; Ritter, Amit; Bachar, Gideon; Mizrachi, Aviram; Shoffel-Havakuk, Hagit; Kurman, Noga; Popovtzer, Aron; Hamzany, Yaniv
发表日期：2025
文献求助 收藏

Management and prognosis of iatrogenic perforations of the cervical oesophagus and hypopharynx

颈段食管和下咽部医源性穿孔的治疗和预后

期刊:Acta Otorhinolaryngologica Italica
影响因子:2.1
doi:10.14639/0392-100X-N2905
Levin, Einav G; Ritter, Amit; Amitai, Amir; Shpitzer, Thomas; Bachar, Gideon; Mizrachi, Aviram; Hamzany, Yaniv
发表日期：2024
文献求助 收藏

Anti-RBD IgG antibodies and neutralizing antibody levels after the second BNT162b2 dose in patients with plasma cell disorders

浆细胞疾病患者在接受第二剂 BNT162b2 后，抗 RBD IgG 抗体和中和抗体水平的变化

期刊:PLoS One
影响因子:2.6
doi:10.1371/journal.pone.0284925
Magen, Hila; Avigdor, Abraham; Nevo, Lee; Fried, Shalev; Gibori, Amit; Levin, Einav G; Lustig, Yaniv; Shkury, Eden; Rahav, Galia
细胞生物学
IgG
发表日期：2023
文献求助 收藏

Long-term complications associated with the management of sinonasal malignancies: a single center experience

鼻窦恶性肿瘤治疗相关的长期并发症：单中心经验

期刊:Acta Otorhinolaryngologica Italica
影响因子:2.1
doi:10.14639/0392-100X-N1902
Levin, Einav G; Tzelnick, Sharon; Yaacobi, Daniel; Vainer, Igor; Mizrachi, Aviram; Popovtzer, Aron; Soudry, Ethan
肿瘤
肿瘤免疫
发表日期：2023
文献求助 收藏

Letter of response to comment on: Efficacy and safety of BNT162b2 vaccination in solid cancer patients receiving anti-cancer therapy - A single centre prospective study

针对以下评论的回复函：BNT162b2疫苗在接受抗癌治疗的实体瘤患者中的疗效和安全性——一项单中心前瞻性研究

期刊:European Journal of Cancer
影响因子:7.1
doi:10.1016/j.ejca.2021.10.019
Shacham-Shmueli, Einat; Itay, Amit; Margalit, Ofer; Berger, Raanan; Halperin, Sharon; Jurkowicz, Menucha; Levin, Einav G; Levy, Itzchak; Olmer, Liraz; Regev-Yochay, Gili; Lustig, Yaniv; Rahav, Galia
肿瘤
肿瘤免疫
发表日期：2022
文献求助 收藏

Seropositivity and neutralising antibodies at six months after BNT162b2 vaccination in patients with solid tumours

实体瘤患者接种BNT162b2疫苗六个月后的血清阳性率和中和抗体

期刊:European Journal of Cancer
影响因子:7.1
doi:10.1016/j.ejca.2022.03.013
Margalit, Ofer; Shacham-Shmueli, Einat; Itay, Amit; Berger, Raanan; Halperin, Sharon; Jurkowicz, Menucha; Levin, Einav G; Olmer, Liraz; Regev-Yochay, Gili; Lustig, Yaniv; Rahav, Galia
发表日期：2022
文献求助 收藏

Immunogenicity and Adverse Effects of the 2-Dose BNT162b2 Messenger RNA Vaccine Among Liver Transplantation Recipients

两剂BNT162b2信使RNA疫苗在肝移植受者中的免疫原性和不良反应

期刊:Liver Transplantation
影响因子:3.9
doi:10.1002/lt.26366
Davidov, Yana; Tsaraf, Keren; Cohen-Ezra, Oranit; Likhter, Mariya; Ben Yakov, Gil; Levy, Itzchak; Levin, Einav G; Lustig, Yaniv; Mor, Orna; Rahav, Galia; Ben Ari, Ziv
免疫/内分泌
发表日期：2022
文献求助 收藏

Coronavirus disease 2019 (COVID-19) vaccination uptake among healthcare workers

医护人员中2019冠状病毒病（COVID-19）疫苗接种率

期刊:Infection Control and Hospital Epidemiology
影响因子:2.9
doi:10.1017/ice.2021.421
Gilboa, Mayan; Tal, Ilana; Levin, Einav G; Segal, Shoshi; Belkin, Ana; Zilberman-Daniels, Tal; Biber, Asaf; Rubin, Carmit; Rahav, Galia; Regev-Yochay, Gili
微生物学
发表日期：2022
文献求助 收藏

Efficacy and safety of BNT162b2 vaccination in patients with solid cancer receiving anticancer therapy - a single centre prospective study

BNT162b2疫苗在接受抗癌治疗的实体瘤患者中的疗效和安全性——一项单中心前瞻性研究

期刊:European Journal of Cancer
影响因子:7.1
doi:10.1016/j.ejca.2021.08.007
Shmueli, Einat S; Itay, Amit; Margalit, Ofer; Berger, Raanan; Halperin, Sharon; Jurkowicz, Menucha; Levin, Einav G; Levy, Itzchak; Olmer, Liraz; Regev-Yochay, Gili; Lustig, Yaniv; Rahav, Galia
肿瘤
肿瘤免疫
发表日期：2021
文献求助 收藏